After a year of stop‑start policy signals, the US cannabis market ended 2025 with a new wave of attention as…
Merck closed the fourth quarter with earnings and revenue ahead of Wall Street estimates, supported by strong demand for its…
After a year of stop‑start policy signals, the US cannabis market ended 2025 with a new wave of attention as…
Merck closed the fourth quarter with earnings and revenue ahead of Wall Street estimates, supported by strong demand for its…